Ouvrez la porte J, Génamique, Google Scholar, ISA (résumés scientifiques indiens), Base de données CAS (Chemical Abstract Services), CABI (Royaume-Uni), Index Copernic, Hinar, EBSCO, Répertoire des périodiques d'Ulrich, Pesticides botaniques , Résumés de mauvaises herbes, AgBiotechNet, Ressource VetMed, Résumés de physiologie des cultures, Abrégés d'agroforesterie, Résumés helminthologiques, Horticulture ornementale, Abrégés de phytogénétiques, Novelles and informations on the porc, Abrégés sur les sciences laitières, Basis der Données sur Landwirtschaftliche Wirtschaft, Basis für Parasitologie-Studien, CAB-Lebensläufe, Zoologisches Register, Neue und nachträgliche Informationen, Basis für Ernährungs- und Lebensmittelwissenschaften, Basis für biologische Forschung, Weltgesundheit, ABC Chimie, Zentrum des Wissenschaften,SCIMAGO ist ein Zug,der viele andere Charaktere verrät.
Priyanshu Sharma
Atherosclerosis is a chronic inflammatory illness in which immune systems work with metabolic risk factors to start, spread, and activate vascular lesions. It is the main cause ..Voir plus»
Manal
Background: Alopecia areata (AA) is the most successive reason for irritation instigated Hair. It is an organ–explicit immune system infection where T cells and cytokines ..Voir plus»
Mehdi Mirzaei-Alavijeh, Parastoo Hossini, Somayeh Hayati, Abbas Aghaei, Behzad Karami-Matin
"Aggressive behavior in college students can be considered as an analyst for crime, drug abuse, depression and academic failure. The aim of this study was to determine the ..Voir plus»
Shyna Maes
The worldwide economy is moving toward additional supportable wellsprings of energy. The transportation area is a noteworthy illustration of this reality, where biofuels have ar..Voir plus»
Masahito Kawabori*, Kota Kurisu, Yoshimasa Niiya, Yuzuru Ohta, Shoji Mabuchi and Kiyohiro Houkin
A rare case of Mollaret meningitis characterized by four recurrent episodes of aseptic meningitis during the 3-year periods were reported. The patient showed high fever and severe ..Voir plus»
Francois Curtin
End of December 2013, alemtuzumab, a monoclonal antibody for multiple sclerosis (MS) with an immunomodulator
action targeting CD52 receptors and inducing decrease counts ..Voir plus»